QUAZAR Trademark

Trademark Overview

On Thursday, June 7, 2012, a trademark application was filed for QUAZAR with the United States Patent and Trademark Office. The USPTO has given the QUAZAR trademark a serial number of 85646218. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 10, 2020. This trademark is owned by Celgene Corporation. The QUAZAR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials; conducting clinical trials on the safety and effectiveness of azacitidine; providing medical and scientific research information in the field of clinical trials
quazar

General Information

Serial Number85646218
Word MarkQUAZAR
Filing DateThursday, June 7, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 10, 2020
Registration Number4442256
Registration DateTuesday, December 3, 2013
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 17, 2013

Trademark Statements

Description of MarkThe mark consists of a diamond shape design with the word "QUAZAR" centered underneath with a line underneath the letters "UAZAR" of the word "QUAZAR".
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical and scientific research, namely, conducting clinical trials; conducting clinical trials on the safety and effectiveness of azacitidine; providing medical and scientific research information in the field of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 10, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, July 10, 2020CANCELLED SEC. 8 (6-YR)
Monday, December 3, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 29, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 3, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, September 17, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2013PUBLISHED FOR OPPOSITION
Wednesday, August 28, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 13, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 13, 2013EXAMINER'S AMENDMENT ENTERED
Tuesday, August 13, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 13, 2013EXAMINERS AMENDMENT E-MAILED
Tuesday, August 13, 2013EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 16, 2013PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, July 5, 2013WITHDRAWN FROM PUB OTQR REQUEST
Tuesday, June 25, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 20, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 20, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 20, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 13, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, June 5, 2013NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, June 5, 2013INQUIRY TO SUSPENSION E-MAILED
Wednesday, June 5, 2013SUSPENSION INQUIRY WRITTEN
Tuesday, June 4, 2013SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, November 26, 2012NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 26, 2012LETTER OF SUSPENSION E-MAILED
Monday, November 26, 2012SUSPENSION LETTER WRITTEN
Monday, October 22, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 22, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 3, 2012ASSIGNED TO LIE
Tuesday, September 25, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 24, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 24, 2012NON-FINAL ACTION E-MAILED
Monday, September 24, 2012NON-FINAL ACTION WRITTEN
Monday, September 24, 2012ASSIGNED TO EXAMINER
Tuesday, June 19, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Monday, June 18, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 11, 2012NEW APPLICATION ENTERED

Related Keywords

quazar clinical trials research medical scientific conducting information field providing safety